Seeking novel leads through structure-based pharmacophore design

Journal of the Brazilian Chemical Society

Volumn 13, Issue 6, 2002, Pages 777-787

  Fisher, Luke S ^a   Güner, Osman F ^a  

^a ACCELRYS INC   (United States)

Author keywords

3D databses; Pharmacophores; Structure based design

Indexed keywords

HESPERIDIN; PEPSTATIN; PROTEINASE; PROTEINASE INHIBITOR; ROBININ; UNCLASSIFIED DRUG;

BINDING SITE; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DRUG DESIGN; DRUG EFFECT; DRUG IDENTIFICATION; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; LIPOPHILICITY; NONHUMAN; PHARMACOPHORE; TECHNIQUE; THREE DIMENSIONAL IMAGING;

EID: 0036985974     PISSN: 01035053     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0103-50532002000600008     Document Type: Conference Paper

References (20)

1. Hansch, C.; Leo, A.; Exploiting QSAR: Fundamentals and Applications in Chemistry and Biology, ACS Professional Reference Book: USA, 1995.
2. Güner, O. F. ed.; Pharmacophore Perception, Development, and Use in Drug Design, International University Line: La Jolla, 2000.
3. Kawakami, Y; Inoue, A.; Kawai, T.; Wakita M.; Sugimoto, H.; Hopfinger, A. J.; Bioorg. Med. Chem. 1996, 4, 1429.
4. Weinstock, J.; Keenan, R. M.; Samanen, J.; Hempel, J.; Finkelstein, J. A.; J. Med. Chem. 1991, 34, 1514.
5. Dorsey, B. D.; Levin, R. B.; McDaniel, S. L.; Vacca, J. P.; Guare, J. P.; J. Med. Chem. 1994, 37, 3443.
6. Kaldor, S.W.; Kalish, V. J.; Davies II, J. F.; Shetty, B. V.; Fritz, J. E.; Appelt, K.; Burgess, J. A.; Campanale, K. M.; Chirgadze, N. Y.; Clawson, D. K.; Dressman, B. A.; Hatch, S. D.; Khalil, D. A.; Kosa, M. B.; Lubbehusen, P. P.; Muesing, M. A.; Patick, A. K.; Reich, S. H.; Su, K. S.; Tatlock, J. H.; J. Med. Chem. 1997, 40, 3979.
7. Güner, O. F.; Henry, D. R. In Pharmacophore Perception, Development, and Use in Drug Design; Güner, O. F. ed., International University Line: La Jolla, 2000, p. 191.
8. Cerius2 and Catalyst are software package available from Accelrys Inc., 9685 Scranton Road, San Diego, CA, 92121, USA, http://www.accelrys.com
9. Hosur, M. V.; Bhat, T. N.; Kempf, D. J.; Baldwin, E. T.; Liu, B. S., Gulnik, S.; Wideburg, N. E.; Norbeck, D. W.; Appelt, K.; Erickson, J. W.; J. Am. Chem. Soc. 1994, 116, 847.
10. Bone, R.; Vacca, J. P.; Anderson, P. S.; Holloway, M. K.; J. Am. Chem. Soc. 1991, 113, 9382.
11. Kirchhoff, P. D.; Brown, R.; Kahn, S.; Waldman, M.; Venkatachalam, C. M.; J. Comput. Chem. 2001, 22, 993.
12. Peters, K.P.; Fauck, J.; Frommel, C.; J. Mol. Biol., 1996 256, 201.
13. Böhm, H.-J.; J. Comput.-Aided Mol. Design 1992, 6, 243.
14. Kurogi, Y.; Güner, O. F.; Curr. Med. Chem. 2001, 8, 1035.
15. Hahn, M.; J. Chem. Inf. Comput. Sci. 1997, 37, 80.
16. Güner, O. F.; Waldman, M.; Hoffman, R.; Kim, J.-H. In Pharmacophore Perception, Development, and Use in Drug Design; Güner, O. F. ed., International University Line: La Jolla, 2000, p 215.
17. Murrall, N. W.; Davies, E. K.; J. Chem. Inf. Comput. Sci. 1990, 30, 312.
18. Derwent, Alexandria, VA USA, http://www.derwent.com/worlddrugindex/. accessed in the Catalyst version of World Drug Index (WDI99).
19. MDL Information Systems, Inc. San Leandro, CA, USA, http://www.mdli.com/products/acd.html, accesed in the Catalyst version of Available Chemical Directory (ACD99).
20. National Cancer Institute, Bethesda, MD, USA, http://www.nci.nih.gov/, accesed in the Catalyst version of the National Cancer Institute database version 2000 (NCI2000).